Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Return on Capital Employed (2016 - 2018)

Historic Return on Capital Employed for Armata Pharmaceuticals (ARMP) over the last 5 years, with Q3 2018 value amounting to 0.96%.

  • Armata Pharmaceuticals' Return on Capital Employed rose 11800.0% to 0.96% in Q3 2018 from the same period last year, while for Sep 2018 it was 0.96%, marking a year-over-year increase of 11800.0%. This contributed to the annual value of 1.27% for FY2017, which is 1800.0% down from last year.
  • According to the latest figures from Q3 2018, Armata Pharmaceuticals' Return on Capital Employed is 0.96%, which was up 11800.0% from 1.42% recorded in Q2 2018.
  • Armata Pharmaceuticals' Return on Capital Employed's 5-year high stood at 0.3% during Q3 2015, with a 5-year trough of 2.58% in Q2 2017.
  • Moreover, its 5-year median value for Return on Capital Employed was 0.51% (2014), whereas its average is 0.9%.
  • Per our database at Business Quant, Armata Pharmaceuticals' Return on Capital Employed crashed by -20500bps in 2017 and then skyrocketed by 11800bps in 2018.
  • Over the past 5 years, Armata Pharmaceuticals' Return on Capital Employed (Quarter) stood at 0.5% in 2014, then skyrocketed by 32bps to 0.34% in 2015, then plummeted by -274bps to 1.26% in 2016, then decreased by -22bps to 1.54% in 2017, then skyrocketed by 37bps to 0.96% in 2018.
  • Its last three reported values are 0.96% in Q3 2018, 1.42% for Q2 2018, and 1.54% during Q4 2017.